Which ASX ETFs hold Guardant Health Inc (GH)?
GH is among the most widely held stocks across ASX-listed ETFs, appearing in approximately 3 ETFs. Its largest single position is approximately 1.22% in JNDQ (BetaShares NASDAQ Next Gen 100 ETF), as at 29 Oct 2026. General information only, not financial advice.
General information only, not financial advice. ETFLens does not hold an AFSL. Always read the relevant PDS and consider seeking advice from a licensed financial adviser.
All weights are approximate, drawn from each fund's most recent holdings file (dated 30 Sep 2026 to 29 Oct 2026), and change as funds rebalance.
| ETF | Fund | Category | Weight |
|---|---|---|---|
| JNDQ | BetaShares NASDAQ Next Gen 100 ETF | US Shares | approx. 1.22% |
| VISM | Vanguard MSCI International Small Companies Index ETF | Global Broad Market | approx. 0.22% |
| VTS | Vanguard US Total Market Shares Index ETF | US Shares | approx. 0.03% |
Want to see what any of these funds overlap with? Try the free ETF overlap checker, or browse the most widely held stocks.
Hold more than one of these? See your combined GH exposure across all your ETFs with the Stock X-Ray.
GH in ETFs: frequently asked questions
Which ASX ETFs hold GH?
Guardant Health Inc (GH) is held by approximately 3 ASX-listed ETFs, including JNDQ, VISM, VTS. General information only.
Which ETF has the largest GH weighting?
JNDQ (BetaShares NASDAQ Next Gen 100 ETF) has the largest GH position at approximately 1.22% of the fund, as at 29 Oct 2026. Past weightings are not a reliable indicator of future weightings.